Osimertinib is used to treat locally advanced or metastatic non-small-cell lung cancer. It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor.Reference standards of Osimertinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => 2,4-Difluoronitrobenzene (BSC) [catalogue_number] => PA BSC 05115877 [category_ids] => ,169, [chemical_name] => [weight] => 159.09 [form] => C6H3F2NO2 [cas] => 446-35-5 [pslug] => 446-35-5-2-4-difluoronitrobenzene-bsc-pabsc05115877 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA BSC 05115877
CAS :
Molecular Formula : C6H3F2NO2
Molecular Weight : 159.09
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....